 BERWYN, Pa., Sept. 10, 2021 PRNewswire -- Annovis Bio, Inc. NYSE American: ANVS Annovis or the Company, a clinical-stage drug platform company addressing Alzheimers disease AD, Parkinsons disease PD and other neurodegenerative diseases, today announced CEO Maria L. 